第 1 到 103 筆結果,共 103 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2020 | A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs | Chen P.-L.; Lee N.-Y.; Cia C.-T.; Ko W.-C.; PO-REN HSUEH | Frontiers in Pharmacology | 45 | 37 | |
2 | 2020 | In vitro susceptibility of ceftaroline against clinically important Gram-positive cocci, Haemophilus species and Klebsiella pneumoniae in Taiwan: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012–2018 | Jean S.-S.; Lee W.-S.; Ko W.-C.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 12 | 10 | |
3 | 2020 | Extra-respiratory manifestations of COVID-19 | Lai C.-C.; Ko W.-C.; PING-ING LEE ; Jean S.-S.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 212 | 184 | |
4 | 2020 | SARS-CoV-2 and COVID-19 | WANG-HUEI SHENG ; Ko W.-C.; Huang Y.-C.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 11 | 7 | |
5 | 2020 | National surveillance of antimicrobial susceptibility of bacteremic gram-negative bacteria with emphasis on community-acquired resistant isolates: Report from the 2019 surveillance of multicenter antimicrobial resistance in Taiwan (SMART) | Liu P.-Y.; Lee Y.-L.; Lu M.-C.; PEI-LAN SHAO ; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Tang H.-J.; Chen Y.-H.; WANG-HUEI SHENG ; Lee C.-M.; Liao M.-H.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 20 | 15 | |
6 | 2020 | Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status | Lai C.-C.; Wang C.-Y.; Wang Y.-H.; Hsueh S.-C.; Ko W.-C.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 269 | 141 | |
7 | 2020 | Arguments in favour of remdesivir for treating SARS-CoV-2 infections | Ko W.-C.; Rolain J.-M.; Lee N.-Y.; Chen P.-L.; Huang C.-T.; PING-ING LEE ; PO-REN HSUEH | International Journal of Antimicrobial Agents | 235 | 85 | |
8 | 2020 | COVID-19 in long-term care facilities: An upcoming threat that cannot be ignored | Lai C.-C.; Wang J.-H.; Ko W.-C.; Yen M.-Y.; Lu M.-C.; Lee C.-M.; PO-REN HSUEH ; Society of Taiwan Long-term Care Infection Prevention and Control | Journal of Microbiology, Immunology and Infection | 66 | 57 | |
9 | 2020 | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges | Lai C.-C.; Shih T.-P.; Ko W.-C.; Tang H.-J.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 3839 | 2509 | |
10 | 2020 | In vitro diagnostics of coronavirus disease 2019: Technologies and application | Lai C.-C.; Wang C.-Y.; Ko W.-C.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 67 | 51 | |
11 | 2020 | Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum β-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012–2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018–2019 | Jean S.-S.; Ko W.-C.; PO-REN HSUEH ; SMART Study Group | International Journal of Antimicrobial Agents | 6 | 6 | |
12 | 2020 | Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016 | Kuo S.-C.; Liu C.-E.; Lu P.-L.; Chen Y.-S.; Lu M.-C.; Ko W.-C.; PO-REN HSUEH ; Chuang Y.-C.; Wang F.-D.; the SMART Asia-Pacific Group | International Journal of Antimicrobial Agents | 28 | 26 | |
13 | 2020 | Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths | Lai C.-C.; Liu Y.H.; Wang C.-Y.; Wang Y.-H.; Hsueh S.-C.; Yen M.-Y.; Ko W.-C.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 628 | 496 | |
14 | 2020 | A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic | Lee N.-Y.; Li C.-W.; Tsai H.-P.; Chen P.-L.; Syue L.-S.; Li M.-C.; Tsai C.-S.; Lo C.-L.; PO-REN HSUEH ; Ko W.-C. | Journal of Microbiology, Immunology and Infection | 41 | 33 | |
15 | 2019 | Prevalence and risk factors for colonization by extended-spectrum β-lactamase-producing or ST 131 escherichia coli among asymptomatic adults in community settings in Southern Taiwan | Wu P.-C.; Wang J.-L.; PO-REN HSUEH ; Lin P.-H.; Cheng M.-F.; Huang I.-F.; Chen Y.-S.; Lee S.S.-J.; Guang-Yuan M.; Yu H.-C.; Hsu C.-L.; Wang F.-W.; Chen C.-S.; Hung C.-H.; Ko W.-C. | Infection and Drug Resistance | 17 | 15 | |
16 | 2019 | Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: Results from surveillance of multicenter antimicrobial resistance in Taiwan (SMART) | Lai C.-C.; Chen Y.-S.; Lee N.-Y.; Tang H.-J.; Lee S.S.-J.; Lin C.-F.; Lu P.-L.; Wu J.-J.; Ko W.-C.; Lee W.-S.; PO-REN HSUEH | Infection and Drug Resistance | 22 | 20 | |
17 | 2019 | Nanoparticles in the treatment of infections caused by multidrug-resistant organisms | Lee N.-Y.; Ko W.-C.; PO-REN HSUEH | Frontiers in Pharmacology | 299 | 256 | |
18 | 2019 | Implementation of a national quality improvement program to enhance hand hygiene in nursing homes in Taiwan | Lai C.-C.; Lu M.-C.; Tang H.-J.; Chen Y.-H.; Wu Y.-H.; Chiang H.-T.; Wu L.-H.; Ko W.-C.; PO-REN HSUEH ; Chen Y.-H.; for Infection Control Society of Taiwan | Journal of Microbiology, Immunology and Infection | 10 | 7 | |
19 | 2019 | National bundle care program implementation to reduce ventilator-associated pneumonia in intensive care units in Taiwan | Kao C.-C.; Chiang H.-T.; Chen C.-Y.; Hung C.-T.; Chen Y.-C.; Su L.-H.; Shi Z.-Y.; Liu J.-W.; Liu C.-P.; Chuang Y.-C.; Ko W.-C.; Chen Y.-H.; Tseng S.-H.; Lee C.-M.; Lu M.-C.; PO-REN HSUEH ; for the Infection Control Society of Taiwan | Journal of Microbiology, Immunology and Infection | 21 | 18 | |
20 | 2019 | Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018 | Lee Y.-L.; Lu M.-C.; PEI-LAN SHAO ; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG ; Lee C.-M.; Liao M.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 40 | 39 | |
21 | 2019 | Antimicrobial activities of ceftazidime-avibactam, ceftolozane-tazobactam, and other agents against escherichia coli, klebsiella pneumoniae, and pseudomonas aeruginosa isolated from intensive care units in Taiwan: Results from the surveillance of multicenter antimicrobial resistance in Taiwan in 2016 | Liao C.-H.; Lee N.-Y.; Tang H.-J.; Lee S.S.J.; Lin C.-F.; Lu P.-L.; Wu J.-J.; Ko W.-C.; Lee W.-S.; PO-REN HSUEH | Infection and Drug Resistance | 25 | 23 | |
22 | 2019 | Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007–2014 | Liu W.-L.; Lai C.-C.; Li M.-C.; Wu C.-J.; Ko W.-C.; Hung Y.-L.; Tang H.-J.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 13 | 13 | |
23 | 2019 | Predominance of methicillin-resistant Staphylococcus aureus in the residents and environments of long-term care facilities in Taiwan | Liu C.-Y.; Lai C.-C.; Chiang H.-T.; Lu M.-C.; Wang L.-F.; Tsai T.-L.; Kang M.-Y.; Jan Y.-N.; Lo Y.-T.; Ko W.-C.; Tseng S.-H.; Lee C.-M.; PO-REN HSUEH ; Infection Control Society of Taiwan | Journal of Microbiology, Immunology and Infection | 22 | 20 | |
24 | 2018 | In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART) | Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; PEI-LAN SHAO ; Ko W.-C.; Wang F.-D.; PO-REN HSUEH | Infection and Drug Resistance | 34 | 34 | |
25 | 2018 | Carbapenem-resistant enterobacteriaceae infections: Taiwan aspects | Jean S.-S.; Lee N.-Y.; Tang H.-J.; Lu M.-C.; Ko W.-C.; PO-REN HSUEH | Frontiers in Microbiology | 40 | 37 | |
26 | 2018 | Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan | Hung Y.-P.; Tsai P.-J.; Lee Y.-T.; Tang H.-J.; Lin H.-J.; Liu H.-C.; Lee J.-C.; Tsai B.-Y.; PO-REN HSUEH ; Ko W.-C. | Infection and Drug Resistance | 19 | 19 | |
27 | 2018 | QuantiFERON-TB gold plus is a more sensitive screening tool than QuantiFERON-TB gold in-tube for latent tuberculosis infection among older adults in long-term care facilities | JUNG-YIEN CHIEN ; Chiang H.-T.; Lu M.-C.; Ko W.-C.; CHONG-JEN YU ; Chen Y.-H.; PO-REN HSUEH | Journal of Clinical Microbiology | 28 | 26 | |
28 | 2018 | Methicillin-resistant Staphylococcus aureus sequence type 45 with high rates of ciprofloxacin and tetracycline resistance in the residents and environments of long-term care facilities in Taiwan | Lai C.-C.; Lee C.-M.; Chiang H.-T.; Lu M.-C.; Wang L.-F.; Tsai T.-L.; Kang M.-Y.; Jan Y.-N.; Lo Y.-T.; Ko W.-C.; Tseng S.-H.; PO-REN HSUEH | Journal of Infection | 8 | 5 | |
29 | 2018 | Clinical characteristics of patients with bacteraemia due to the emergence of mcr-1-harbouring Enterobacteriaceae in humans and pigs in Taiwan | Lai C.-C.; Lin Y.-T.; Lin Y.-T.; Lu M.-C.; Shi Z.-Y.; Chen Y.-S.; Wang L.-S.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH ; Infection Control Society of Taiwan | International Journal of Antimicrobial Agents | 20 | 16 | |
30 | 2018 | Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan? | Lu P.-L.; Liu W.-L.; Lo H.-J.; Wang F.-D.; Ko W.-C.; PO-REN HSUEH ; Ho M.-W.; Liu C.-E.; Chen Y.-H.; YEE-CHUN CHEN ; Chuang Y.-C.; SHAN-CHWEN CHANG | Journal of the Formosan Medical Association | 15 | 10 | |
31 | 2018 | Corrigendum to “Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)” [J Microbiol Immunol Infect 49 (2016) 969–976] (S1684118215000213) (10.1016/j.jmii.2014.12.008)) | Jean S.-S.; Lee W.-S.; Yu K.-W.; Liao C.-H.; Hsu C.-W.; Chang F.-Y.; Ko W.-C.; Chen R.-J.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Lam C.; Liu C.-Y.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 4 | 2 | |
32 | 2018 | Implementation of a national bundle care program to reduce central line-associated bloodstream infections in intensive care units in Taiwan | Lai C.-C.; Cia C.-T.; Chiang H.-T.; Kung Y.-C.; Shi Z.-Y.; Chuang Y.-C.; Lee C.-M.; Ko W.-C.; PO-REN HSUEH ; for the Infection Control Society of Taiwan | Journal of Microbiology, Immunology and Infection | 15 | 13 | |
33 | 2017 | Corrigendum to “Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009” [Diagn Microbiol Infect Dis 2015;81(4):290–295] (S0732889314004076)(10.1016/j.diagmicrobio.2014.09.027) | Jean S.-S.; Lee W.-S.; Bai K.-J.; Yu K.-W.; Hsu C.-W.; Liao C.-H.; Chang F.-Y.; Ko W.-C.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Liu C.-Y.; Chen R.-J.; PO-REN HSUEH | Diagnostic Microbiology and Infectious Disease | 0 | 0 | |
34 | 2017 | Implementation of a national bundle care program to reduce catheter-associated urinary tract infection in high-risk units of hospitals in Taiwan | Lai C.-C.; Lee C.-M.; Chiang H.-T.; Hung C.-T.; Chen Y.-C.; Su L.-H.; Shi Z.-Y.; Liu J.-W.; Liu C.-P.; Lu M.-C.; Chuang Y.-C.; Ko W.-C.; Tseng S.-H.; Chen Y.-H.; PO-REN HSUEH ; for the, Infection Control Society of Taiwan | Journal of Microbiology, Immunology and Infection | 13 | 10 | |
35 | 2017 | Presence of multidrug-resistant organisms in the residents and environments of long-term care facilities in Taiwan | Lee C.-M.; Lai C.-C.; Chiang H.-T.; Lu M.-C.; Wang L.-F.; Tsai T.-L.; Kang M.-Y.; Jan Y.-N.; Lo Y.-T.; Ko W.-C.; Tseng S.-H.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 42 | 40 | |
36 | 2017 | Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae | Lo C.-L.; Lee C.-C.; Li C.-W.; Li M.-C.; PO-REN HSUEH ; Lee N.-Y.; Ko W.-C. | Journal of Microbiology, Immunology and Infection | 23 | 6 | |
37 | 2017 | Role of rifampin for the treatment of bacterial infections other than mycobacteriosis | Lee C.-Y.; Huang C.-H.; Lu P.-L.; Ko W.-C.; Chen Y.-H.; PO-REN HSUEH | Journal of Infection | 19 | 17 | |
38 | 2016 | Monomicrobial Aeromonas and Vibrio bacteremia in cirrhotic adults in southern Taiwan: Similarities and differences | Syue L.-S.; Chen P.-L.; Wu C.-J.; Lee N.-Y.; Lee C.-C.; Li C.-W.; Li M.-C.; Tang H.-J.; PO-REN HSUEH ; Ko W.-C. | Journal of Microbiology, Immunology and Infection | 11 | 9 | |
39 | 2016 | RNA polymerase B subunit gene mutations in?biofilm-embedded methicillin-resistant Staphylococcus aureus following rifampin treatment | Tang H.-J.; Lai C.-C.; PO-REN HSUEH ; Chen C.-C.; Wu K.-Y.; Lin Y.-C.; Zhang C.-C.; Weng T.-C.; Chiu Y.-H.; Toh H.-S.; Chiang S.-R.; Yu W.-L.; Ko W.-C.; Chuang Y.-C. | Journal of Microbiology, Immunology and Infection | 9 | 9 | |
40 | 2016 | New drugs for the treatment of complicated intra-abdominal infections in the era of increasing antimicrobial resistance | Syue L.-S.; Chen Y.-H.; Ko W.-C.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 38 | 34 | |
41 | 2016 | Bacteremic pneumonia caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Appropriateness of empirical treatment matters | Cheng W.-L.; PO-REN HSUEH ; Lee C.-C.; Li C.-W.; Li M.-J.; Chang C.-M.; Lee N.-Y.; Ko W.-C. | Journal of Microbiology, Immunology and Infection | 28 | 28 | |
42 | 2016 | Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) | Jean S.-S.; Lee W.-S.; Yu K.-W.; Liao C.-H.; Hsu C.-W.; Chang F.-Y.; Ko W.-C.; Chen R.-J.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Lam C.; Liu C.-Y.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 20 | 15 | |
43 | 2016 | Recent developments in antibiotic agents for the treatment of complicated intra-abdominal infections | Lin S.-Y.; Huang C.-H.; Ko W.-C.; Chen Y.-H.; PO-REN HSUEH | Expert Opinion on Pharmacotherapy | 7 | 5 | |
44 | 2015 | Evaluation of the bruker biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of blood isolates of vibrio species | WERN-CHERNG CHENG ; I-SHIOW JAN ; JONG-MIN CHEN ; Teng S.-H.; LEE-JENE TENG ; WANG-HUEI SHENG ; Ko W.-C.; PO-REN HSUEH | Journal of Clinical Microbiology | 31 | 26 | |
45 | 2015 | Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007 | Jean S.-S.; Lee W.-S.; Bai K.-J.; Lam C.; Hsu C.-W.; Yu K.-W.; Liao C.-H.; Chang F.-Y.; Ko W.-C.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Liu C.-Y.; Chen R.-J.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 12 | 9 | |
46 | 2015 | Clinical implications of species identification in monomicrobial Aeromonas bacteremia | Wu C.-J.; Chen P.-L.; PO-REN HSUEH ; Chang M.-C.; Tsai P.-J.; Shih H.-I.; Wang H.-C.; Chou P.-H.; Ko W.-C. | PLoS ONE | 37 | 35 | |
47 | 2015 | Disease burden of invasive listeriosis and molecular characterization of clinicalisolates in Taiwan, 2000-2013 | YU-TSUNG HUANG ; Ko W.-C.; Chan Y.-J.; Lu J.-J.; Tsai H.-Y.; Liao C.-H.; WANG-HUEI SHENG ; LEE-JENE TENG ; PO-REN HSUEH | PLoS ONE | 36 | 40 | |
48 | 2015 | Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009 | Jean S.-S.; Lee W.-S.; Bai K.-J.; Yu K.-W.; Hsu C.-W.; Liao C.-H.; Chang F.-Y.; Ko W.-C.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Liu C.-Y.; Chen R.-J.; PO-REN HSUEH | Diagnostic Microbiology and Infectious Disease | 5 | 7 | |
49 | 2014 | Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase-producing Proteus mirabilis | Tsai H.-Y.; Chen Y.-H.; Tang H.-J.; Huang C.-C.; Liao C.-H.; Chu F.-Y.; Chuang Y.-C.; WANG-HUEI SHENG ; Ko W.-C.; PO-REN HSUEH | Diagnostic Microbiology and Infectious Disease | 38 | 35 | |
50 | 2014 | Clostridium difficile ribotype 126 in southern Taiwan: A cluster of three symptomatic cases | Hung Y.-P.; Lin H.-J.; Tsai B.-Y.; Liu H.-C.; Liu H.-C.; Lee J.-C.; Wu Y.-H.; Wilcox M.H.; Fawley W.N.; PO-REN HSUEH ; Tsai P.-J.; Ko W.-C. | Anaerobe | 22 | 22 | |
51 | 2014 | Trends in the susceptibility of methicillin-resistant Staphylococcus aureus to nine antimicrobial agents, including ceftobiprole, nemonoxacin, and tyrothricin: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006-2010 | Chen Y.-H.; Liu C.-Y.; Ko W.-C.; Liao C.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 22 | 19 | |
52 | 2014 | Matrix-assisted laser desorption ionization-time of flight mass spectrometry can accurately differentiate Aeromonas dhakensis from A. hydrophila, A. caviae, and A. veronii | Chen P.-L.; Lee T.-F.; Wu C.-J.; Teng S.-H.; LEE-JENE TENG ; Ko W.-C.; PO-REN HSUEH | Journal of Clinical Microbiology | 26 | 25 | |
53 | 2014 | Clinical characteristics of patients with community-acquired complicated intra-abdominal infections: a prospective, multicentre, observational study | Jean S.-S.; Ko W.-C.; Xie Y.; Pawar V.; Zhang D.; Prajapati G.; Mendoza M.; Kiratisin P.; Ramalheira E.; Castro A.P.; Rosso F.; PO-REN HSUEH | International journal of antimicrobial agents | 11 | 11 | |
54 | 2013 | Decline in ciprofloxacin-resistant salmonella enterica serovar choleraesuis in Taiwan, 2001-2011 | Liao C.-H.; Ko W.-C.; PO-REN HSUEH | Clinical Infectious Diseases | 5 | 5 | |
55 | 2013 | Reply to altshuler et al | Lee N.-Y.; Lee C.-C.; Li C.-W.; PO-REN HSUEH ; Ko W.-C. | Clinical Infectious Diseases | 3 | 3 | |
56 | 2013 | Characteristics of patients with Clostridium difficile infection in Taiwan | Lin Y.-C.; YU-TSUNG HUANG ; Lee T.-F.; Lee N.-Y.; Liao C.-H.; Lin S.-Y.; Ko W.-C.; PO-REN HSUEH | Epidemiology and Infection | 8 | 6 | |
57 | 2013 | Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing enterobacteriaceae: MIC matters | Lee N.-Y.; Lee C.-C.; Huang W.-H.; Tsui K.-C.; PO-REN HSUEH ; Ko W.-C. | Clinical Infectious Diseases | 147 | 139 | |
58 | 2013 | Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections | Chen Y.-H.; Ko W.-C.; PO-REN HSUEH | Expert Opinion on Pharmacotherapy | 59 | 56 | |
59 | 2013 | Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006-2010 | Tsai H.-Y.; Chen Y.-H.; Liao C.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 11 | 11 | |
60 | 2013 | Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: Results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009 | Jean S.-S.; PO-REN HSUEH ; Lee W.-S.; Yu K.-W.; Liao C.-H.; Chang F.-Y.; Ko W.-C.; Wu J.-J.; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Liu C.-Y.; Lam C.; Chen R.-J. | International Journal of Antimicrobial Agents | 25 | 25 | |
61 | 2012 | Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) | Lu P.-L.; Liu Y.-C.; Toh H.-S.; Lee Y.-L.; Liu Y.-M.; Ho C.-M.; Huang C.-C.; Liu C.-E.; Ko W.-C.; Wang J.-H.; Tang H.-J.; Yu K.-W.; Chen Y.-S.; Chuang Y.-C.; Xu Y.; Ni Y.; Chen Y.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 151 | 135 | |
62 | 2012 | In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) | Liu Y.-M.; Chen Y.-S.; Toh H.-S.; Huang C.-C.; Lee Y.-L.; Ho C.-M.; Lu P.-L.; Ko W.-C.; Chen Y.-H.; Wang J.-H.; Tang H.-J.; Yu K.-W.; Liu Y.-C.; Chuang Y.-C.; Xu Y.; Ni Y.; Liu C.-E.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 34 | 26 | |
63 | 2012 | Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus | Wang J.-L.; Tang H.-J.; Hsieh P.-H.; Chiu F.-Y.; Chen Y.-H.; Chang M.-C.; Huang C.-T.; Liu C.-P.; Lau Y.-J.; Hwang K.-P.; Ko W.-C.; CHEN-TI WANG ; Liu C.-Y.; Liu C.-L.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 30 | 30 | |
64 | 2012 | Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010 | Toh H.-S.; Chuang Y.-C.; Huang C.-C.; Lee Y.-L.; Liu Y.-M.; Ho C.-M.; Lu P.-L.; Liu C.-E.; Chen Y.-H.; Wang J.-H.; Ko W.-C.; Yu K.-W.; Liu Y.-C.; Chen Y.-S.; Tang H.-J.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 7 | 6 | |
65 | 2012 | Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010 | Huang C.-C.; Chen Y.-S.; Toh H.-S.; Lee Y.-L.; Liu Y.-M.; Ho C.-M.; Lu P.-L.; Liu C.-E.; Chen Y.-H.; Wang J.-H.; Tang H.-J.; Yu K.-W.; Liu Y.-C.; Chuang Y.-C.; Xu Y.; Ni Y.; Ko W.-C.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 39 | 33 | |
66 | 2012 | Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010 | Ho C.-M.; Ho M.-W.; Liu Y.-C.; Toh H.-S.; Lee Y.-L.; Liu Y.-M.; Huang C.-C.; Lu P.-L.; Liu C.-E.; Chen Y.-H.; Ko W.-C.; Tang H.-J.; Yu K.-W.; Chen Y.-S.; Chuang Y.-C.; Wang J.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 19 | 18 | |
67 | 2012 | Trends in the susceptibility of clinically important resistant bacteria to tigecycline: Results from the tigecycline In Vitro surveillance in Taiwan study, 2006 to 2010 | Chen Y.-H.; Lu P.-L.; Huang C.-H.; Liao C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 39 | 35 | |
68 | 2012 | The role of fluoroquinolones in the management of urinary tract infections in areas with high rates of fluoroquinolone-resistant uropathogens | Chen Y.-H.; Ko W.-C.; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 24 | 19 | |
69 | 2012 | Role of moxifloxacin for the treatment of commmunity-acquired complicated intra-abdominal infections in Taiwan | Lau Y.-J.; Chen Y.-H.; Huang C.-T.; Lee W.-S.; Liu C.-Y.; Liu J.-W.; Liu H.-D.; Lee Y.-J.; Chen C.-W.; Ko W.-C.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 10 | 11 | |
70 | 2012 | Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2008 to 2010 | Liu J.-W.; Ko W.-C.; Huang C.-H.; Liao C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Chen Y.-H.; Lu P.-L.; Sun W.; Wang L.-S.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 29 | 27 | |
71 | 2012 | Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010 | Lee Y.-L.; Chen Y.-S.; Toh H.-S.; Huang C.-C.; Liu Y.-M.; Ho C.-M.; Lu P.-L.; Ko W.-C.; Chen Y.-H.; Wang J.-H.; Tang H.-J.; Yu K.-W.; Liu Y.-C.; Chuang Y.-C.; Liu C.-E.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 28 | 25 | |
72 | 2012 | Carbapenem therapy for bacteremia due to extended-spectrum-β- lactamase-producing Escherichia coli or Klebsiella pneumoniae: Implications of ertapenem susceptibility | Lee N.-Y.; Lee C.-C.; Huang W.-H.; Tsui K.-C.; PO-REN HSUEH ; Ko W.-C. | Antimicrobial Agents and Chemotherapy | 39 | 38 | |
73 | 2012 | Erratum to "Role of moxifloxacin for the treatment of commmunity-acquired complicated intra-abdominal infections in Taiwan" | Lau Y.-J.; Chen Y.-H.; Huang C.-T.; Lee W.-S.; Liu C.-Y.; Liu J.-W.; Liu H.-D.; Lee Y.-J.; Chen C.-W.; Ko W.-C.; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 0 | 0 | |
74 | 2012 | Characterizations of clinical isolates of Clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: A multicenter study in Taiwan | Liao C.-H.; Ko W.-C.; Lu J.-J.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 49 | 40 | |
75 | 2012 | Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010 | Tsai H.-Y.; Liao C.-H.; Chen Y.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 20 | 19 | |
76 | 2011 | Correlation between fluoroquinolone consumption in hospitals and ciprofloxacin resistance amongst Pseudomonas aeruginosa isolates causing healthcare-associated infections, Taiwan, 2000-2009 | Weng T.-C.; Chen Y.-H.; Lee C.-C.; Wang C.-Y.; Lai C.-C.; Tang H.-J.; Ko W.-C.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 5 | 4 | |
77 | 2011 | Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region | PO-REN HSUEH ; Hoban D.J.; Carmeli Y.; SHEY-YING CHEN ; Desikan S.; Alejandria M.; Ko W.-C.; Binh T.Q. | Journal of Infection | 115 | 96 | |
78 | 2011 | Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: Report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010 | Wang H.; Chen M.; Xu Y.; Sun H.; Yang Q.; Hu Y.; Cao B.; Chu Y.; Liu Y.; Zhang R.; Yu Y.; Sun Z.; Zhuo C.; Ni Y.; Hu B.; Tan T.Y.; PO-REN HSUEH ; Wang J.-H.; Ko W.-C.; Chen Y.-H.; Wahjono H. | International Journal of Antimicrobial Agents | 41 | 36 | |
79 | 2011 | A new health threat in Europe: Shiga toxin-producing Escherichia coli O104:H4 infections | Wu C.-J.; PO-REN HSUEH ; Ko W.-C. | Journal of Microbiology, Immunology and Infection | 33 | 30 | |
80 | 2011 | Consensus statement on the role of fluoroquinolones in the management of urinary tract infections | PO-REN HSUEH ; Lau Y.-J.; Ko W.-C.; Liu C.-Y.; Huang C.-T.; Yen M.-Y.; Liu Y.-C.; Lee W.-S.; Liao C.-H.; Peng M.-Y.; Chen C.-M.; Chen Y.-S. | Journal of Microbiology, Immunology and Infection | 10 | 10 | |
81 | 2011 | Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae | Wang S.-S.; Lee N.-Y.; PO-REN HSUEH ; Huang W.-H.; Tsui K.-C.; Lee H.-C.; Wu C.-J.; Chang C.-M.; Huang C.-C.; Huang C.-F.; Ko W.-C. | Journal of Microbiology, Immunology and Infection | 33 | 32 | |
82 | 2011 | Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae | Lee N.-Y.; Huang W.-H.; Tsui K.-C.; PO-REN HSUEH ; Ko W.-C. | Diagnostic Microbiology and Infectious Disease | 23 | 23 | |
83 | 2011 | Multicenter study in Taiwan of the in Vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species | Lai C.-C.; Liu W.-L.; Ko W.-C.; Chen Y.-H.; Tan H.-R.; YU-TSUNG HUANG ; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 54 | 44 | |
84 | 2011 | Antimicrobial susceptibilities and molecular epidemiology of clinical isolates of Clostridium difficile in Taiwan | Lin Y.-C.; YU-TSUNG HUANG ; Tsai P.-J.; Lee T.-F.; Lee N.-Y.; Liao C.-H.; Lin S.-Y.; Ko W.-C.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 43 | 38 | |
85 | 2011 | Antimicrobial-resistant Nocardia isolates, Taiwan, 1998-2009 | Lai C.-C.; Liu W.-L.; Ko W.-C.; Chen Y.-H.; Tang H.-J.; YU-TSUNG HUANG ; PO-REN HSUEH | Clinical Infectious Diseases | 40 | 35 | |
86 | 2010 | Consensus Statement on the Adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in Clinical Microbiology Laboratories in Taiwan | PO-REN HSUEH ; Ko W.-C.; Wu J.-J.; Lu J.-J.; Wang F.-D.; Wu H.-Y.; Wu T.-L.; LEE-JENE TENG | Journal of Microbiology, Immunology and Infection | 75 | 68 | |
87 | 2010 | Emergence and distribution of plasmids bearing the blaOXA-51- like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan | Chen T.-L.; Lee Y.-T.; Kuo S.-C.; PO-REN HSUEH ; Chang F.-Y.; Siu L.-K.; Ko W.-C.; Fung C.-P. | Antimicrobial Agents and Chemotherapy | 105 | 104 | |
88 | 2010 | Clostridium difficile Bacteremia, Taiwan | Lee N.-Y.; YU-TSUNG HUANG ; PO-REN HSUEH ; Ko W.-C. | Emerging Infectious Diseases | 39 | 36 | |
89 | 2010 | In vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: Nationwide data from the SMART Programme | Jean S.-S.; PO-REN HSUEH ; Lee W.-S.; Chang H.-T.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; LEE-JENE TENG ; Liu C.-Y. | European Journal of Clinical Microbiology and Infectious Diseases | 21 | 16 | |
90 | 2009 | Increasing extended-spectrum β-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: Data from the Smart Study 2002-2006 | Ko W.-C.; PO-REN HSUEH | Journal of Infection | 47 | 45 | |
91 | 2009 | Nationwide surveillance of antimicrobial resistance among haemophilus influenzae and streptococcus pneumoniae in intensive care units in Taiwan | Jean S.-S.; PO-REN HSUEH ; Lee W.-S.; Chang H.-T.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; LEE-JENE TENG ; Liu C.-Y. | European Journal of Clinical Microbiology and Infectious Diseases | 20 | 17 | |
92 | 2009 | Nationwide surveillance of antimicrobial resistance among non-fermentative Gram-negative bacteria in Intensive Care Units in Taiwan: SMART programme data 2005 | Jean S.-S.; PO-REN HSUEH ; Lee W.-S.; Chang H.-T.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; LEE-JENE TENG ; Liu C.-Y. | International Journal of Antimicrobial Agents | 42 | 40 | |
93 | 2009 | Nationwide surveillance of antimicrobial resistance among Enterobacteriaceae in intensive care units in Taiwan | Jean S.-S.; PO-REN HSUEH ; Lee W.-S.; Chang H.-T.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; LEE-JENE TENG ; Liu C.-Y. | European Journal of Clinical Microbiology and Infectious Diseases | 27 | 23 | |
94 | 2008 | Antimicrobial resistance of rapidly growing mycobacteria in Western Taiwan: SMART Program 2002 | Huang T.-S.; Lee S.S.-J.; PO-REN HSUEH ; Tsai H.-C.; Chen Y.-S.; Wann S.-R.; Leu H.-S.; Ko W.-C.; Yan J.-J.; Yuan S.-Z.; Chang F.-Y.; Lu J.-J.; Wang J.-H.; Wang H.-K.; Liu Y.-C. | Journal of the Formosan Medical Association | 22 | 21 | |
95 | 2007 | In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data | Hung M.-N.; PO-REN HSUEH ; Chang H.-T.; Lee W.-S.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; LEE-JENE TENG ; Liu C.-Y.; KWEN-TAY LUH | International Journal of Antimicrobial Agents | 13 | 8 | |
96 | 2006 | Prognostic factors and antibiotics in Vibrio vulnificus septicemia | Liu J.-W.; Lee I.-K.; Tang H.-J.; Ko W.-C.; Lee H.-C.; Liu Y.-C.; PO-REN HSUEH ; Chuang Y.-C. | Archives of Internal Medicine | 77 | 73 | |
97 | 2006 | Characterization of acquired β-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: The prevalence of unusual integrons | Yan J.-J.; PO-REN HSUEH ; Lu J.-J.; Chang F.-Y.; Ko W.-C.; Wu J.-J. | Journal of Antimicrobial Chemotherapy | 46 | 40 | |
98 | 2005 | Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: Surveillance of Multicenter Antimicrobial Resistance in Taiwan program data from 2003 | PO-REN HSUEH ; Lau Y.-J.; Chuang Y.-C.; Wan J.-H.; Huang W.-K.; Shyr J.-M.; Yan J.-J.; Yu K.-W.; Wu J.-J.; Ko W.-C.; Yang Y.-C.; Liu Y.-C.; LEE-JENE TENG ; Liu C.-Y.; KWEN-TAY LUH | Antimicrobial Agents and Chemotherapy | 90 | 74 | |
99 | 2004 | Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from Pigs to Humans, Taiwan | PO-REN HSUEH ; LEE-JENE TENG ; Tseng S.-P.; Chang C.-F.; Wan J.-H.; Yan J.-J.; Lee C.-M.; Chuang Y.-C.; Huang W.-K.; Yang D.; Shyr J.-M.; Yu K.-W.; Wang L.-S.; Lu J.-J.; Ko W.-C.; Wu J.-J.; Chang F.-Y.; Yang Y.-C.; Lau Y.-J.; Liu Y.-C.; Liu C.-Y.; Ho S.-W.; KWEN-TAY LUH | Emerging Infectious Diseases | 93 | 85 | |
100 | 2003 | Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and β-lactams: SMART program 2001 data | PO-REN HSUEH ; LEE-JENE TENG ; Wu T.-L.; Yang D.; Huang W.-K.; Shyr J.-M.; Chuang Y.-C.; Wan J.-H.; Yan J.-J.; Lu J.-J.; Wu J.-J.; Ko W.-C.; Chang F.-Y.; Yang Y.-C.; Lau Y.-J.; Liu Y.-C.; Lee C.-M.; Leu H.-S.; Liu C.-Y.; KWEN-TAY LUH | Antimicrobial Agents and Chemotherapy | 36 | 34 | |
101 | 2003 | Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART program 2001 data | PO-REN HSUEH ; LEE-JENE TENG ; Lee C.-M.; Huang W.-K.; Wu T.-L.; Wan J.-H.; Yang D.; Shyr J.-M.; Chuang Y.-C.; Yan J.-J.; Lu J.-J.; Wu J.-J.; Ko W.-C.; Chang F.-Y.; Yang Y.-C.; Lau Y.-J.; Liu Y.-C.; Leu H.-S.; Liu C.-Y.; KWEN-TAY LUH | Antimicrobial Agents and Chemotherapy | 32 | 26 | |
102 | 2001 | Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme | Yan J.-J.; PO-REN HSUEH ; Ko W.-C.; KWEN-TAY LUH ; Tsai S.-H.; Wu H.-M.; Wu J.-J. | Antimicrobial Agents and Chemotherapy | 246 | 209 | |
103 | 2001 | Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan | PO-REN HSUEH ; Liu Y.-C.; Yang D.; Yan J.-J.; Wu T.-L.; Huang W.-K.; Wu J.-J.; Ko W.-C.; Leu H.-S.; Yu C.-R.; KWEN-TAY LUH | Microbial Drug Resistance | 66 | 61 |